NCT06401122

Brief Summary

  • How dyslipidemia common among Diabetic and non- Diabetic Haemodialysis patients.
  • How differ dyslipidemia types among Diabetic and non- Diabetic in Haemodialysis patients. (Qualitative difference).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

May 6, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

May 2, 2024

Last Update Submit

May 2, 2024

Conditions

Keywords

haemodialysis diabetes mellitus

Outcome Measures

Primary Outcomes (1)

  • dyslipidemia prevalence among Diabetic versus non- Diabetic Haemodialysis patients

    haemodialysis patients for more than six months, and is with diabetes related to affect prevalance of dyslipidemia among these patients

    baseline

Study Arms (2)

diabetic dialysis patients

fifty diabetic patients on regular haemodialysis more than 6 months

Procedure: haemodialysis

Non-diabetic dialysis patients

fifty Non-diabetic patients on regular haemodialysis more than 6 months

Procedure: haemodialysis

Interventions

haemodialysisPROCEDURE

process of filtering the blood of a person whose kidneys are not working normally from uremic toxins

Non-diabetic dialysis patientsdiabetic dialysis patients

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

haemodialysis patients for more than six months, and is with diabetes related to affect prevalance of dyslipidemia among these patients

You may qualify if:

  • Patients aged between 18 and 60 years.
  • Patients undergoing regular conventional Haemodialysis for more than 6 months

You may not qualify if:

  • Peritoneal Dialysis
  • Haemodiafilteration
  • Acute Kidney Injury
  • Nephrotic syndrome
  • Hypothyroidism
  • Familial hypertriglyceridemia.
  • Acute pancreatitis
  • Connective tissue disease.
  • Decompensated liver disease
  • Active malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Biadgo B, Abebe SM, Baynes HW, Yesuf M, Alemu A, Abebe M. Correlation between Serum Lipid Profile with Anthropometric and Clinical Variables in Patients with Type 2 Diabetes Mellitus. Ethiop J Health Sci. 2017 May;27(3):215-226. doi: 10.4314/ejhs.v27i3.3.

    PMID: 29217920BACKGROUND
  • Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88-98. doi: 10.1038/nrendo.2017.151. Epub 2017 Dec 8.

    PMID: 29219149BACKGROUND
  • Ariyanti R, Besral B. Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta. J Lipids. 2019 Apr 30;2019:2517013. doi: 10.1155/2019/2517013. eCollection 2019.

    PMID: 31183219BACKGROUND
  • Hasan YK, Alsultan M, Anan MT, Hassn Q, Basha K. The prevalence of dyslipidemia in patients on hemodialysis: a cross-sectional study from Syria. Ann Med Surg (Lond). 2023 Jun 5;85(8):3838-3844. doi: 10.1097/MS9.0000000000000931. eCollection 2023 Aug.

    PMID: 37554881BACKGROUND

MeSH Terms

Conditions

Dyslipidemias

Interventions

Dialysis

Condition Hierarchy (Ancestors)

Lipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesChemical Phenomena

Study Officials

  • Salwa S. Elgendi, professor

    Assiut University

    STUDY DIRECTOR
  • Essam M. Abdel-Aziz, doctor

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

dina A. Abudeif, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

May 2, 2024

First Posted

May 6, 2024

Study Start

June 1, 2024

Primary Completion

June 1, 2025

Study Completion

December 30, 2025

Last Updated

May 6, 2024

Record last verified: 2024-05